Rockwell Medical Inc (FRA:RWMA)
€ 1.698 0.002 (0.12%) Market Cap: 52.47 Mil Enterprise Value: 57.65 Mil PE Ratio: 0 PB Ratio: 2.66 GF Score: 49/100

Q4 2022 Rockwell Medical Inc Earnings Call Transcript

Mar 30, 2023 / 12:00PM GMT
Release Date Price: €1.44 (+15.20%)
Operator

Good morning, and welcome to Rockwell Medical's Fourth Quarter and Full Year 2022 Results Conference Call and Webcast.

Please note, this event is being recorded. At this time, I would like to turn the conference call over to Heather Hunter, Senior Vice President, Chief Corporate Affairs Officer at Rockwell Medical. Heather, please go ahead.

Heather R. Hunter
Rockwell Medical, Inc. - Senior VP & Chief Corporate Affairs Officer

Good morning, and thank you for joining us for this update on Rockwell Medical. Joining me on today's conference call are Dr. Mark Strobeck, Rockwell Medical's President and Chief Executive Officer; Tim Chole, Rockwell Medical's Senior Vice President, Sales and Marketing; and Paul McGarry, Rockwell Medical's Senior Vice President, Finance and Chief Accounting Officer.

Before we begin, I would like to remind you that this conference call will contain forward-looking statements about Rockwell Medical within the meaning of the Federal Securities Laws, including, but not limited to, the types of statements identified as

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot